Botulinum toxin type b
Myobloc, NeuroBloc (botulinum toxin type b) is an unknown pharmaceutical. Botulinum toxin type b was first approved as Myobloc on 2001-01-22. It is used to treat sialorrhea in the USA. It has been approved in Europe to treat torticollis.
| Trade Name | NeuroBloc |
|---|---|
| Common Name | Botulinum toxin type b |
| Indication | sialorrhea, torticollis |
| Drug Class | Fluoroquinolone derivatives, nonantibacterial indications (e.g., antineoplastic antibiotics) |
